The damaged hearts of laboratory monkeys have been repaired successfully for the first time with human stem cells, in a study that could lead to the first clinical trials on patients with heart disease within the next four years, scientists have announced.
The study demonstrates that human stem cells can be grown in sufficiently large quantities to form beating cardiac muscle tissue which can be stored in frozen form until needed for a transplant operation, the researchers said.
Experiments involving the injection of human stem cells into the damaged hearts of mice, rats and guinea pigs have already shown the potential for treating heart disease. But the latest study, published in the journal Nature, is the first to prove its potential in a non-human primate species, the pintail macaque monkey.
"The main significance of this study is that it shows for the first time that we can do heart regeneration at a scale that the world has never seen before," said Charles Murry, professor of pathology and bioengineering at the University of Washington, in Seattle.
Read more:
• Cells from pigs make muscles in men - research